Search Results 471-480 of 16654 for pharmacogenetics
Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.
The Proteases in Cancer Lab led by Evette S. Radisky, Ph.D., at Mayo Clinic studies proteases and designs better agents for blocking tumor invasion and the ...
Learn how Mayo Clinic's Division of Clinical Trials and Biostatistics provides high-value analytical collaborations and research services to investigators.
Mayo Clinic neurology experts are presenting research findings on Parkinson's disease, Alzheimer's disease, sleep disorders, concussions, multiple sclerosis and ...
ROCHESTER, Minn. — At Mayo Clinic, cardiologists Peter Noseworthy, M.D., and John Giudicessi, M.D., Ph.D., are uncovering the earliest signs of a genetic heart ...
The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...
The purpose of this study is to investigate the safety and tolerability of a single intravenous (IV) dose of SGT-501. Participation eligibility. Participant ...
Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling ...
The purpose of this study is to compare the effects (good and bad) on patients with prostate cancer by comparing the standard dose of radiation therapy (44 ...
Rochester, Minn. The purpose of this study is to see if different depths of submucosal tumor invasion in esophageal cancer can predict lymph node involvement ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift can go 3X as far to shape the future of cancer care.